All 76 IDNA (ISHARES GENOMICS IMMUNOLOGY AND HEALTHCARE ETF) Holdings
There are 76 IDNA holdings. Top 10 companies weight: 47.17%.
Total Market Cap: $660B
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (76 stocks) | +11.53% | 23.75 | 24.00 | 3.28 | +16.07% | +10.59% | 0.59 | ||||||||||
1 | RVMD | Revolution Medicines Inc Ordinary Shares | 7.00% | $180.39 | $37B | Biotechnology | Healthcare | +30.12% | N/A | N/A | N/A | N/A | N/A | 78 | +11.15% | $201 | +42.94% | 1.09 |
2 | MRNA | Moderna Inc | 6.44% | $59.49 | $27B | Biotechnology | Healthcare | N/A | N/A | 23.04 | N/A | N/A | N/A | 46 | -18.88% | $48 | -28.62% | 1.37 |
3 | n/a | Ipsen Sa | 5.17% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
4 | n/a | Takeda Pharmaceutical Co Ltd | 4.43% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
5 | MRK | Merck & Co Inc | 4.27% | $124.40 | $292B | Drug Manufacturers - General | Healthcare | +5.37% | 26.93 | 47.17 | 6.13 | N/A | N/A | 68 | +7.75% | $134 | +13.73% | 0.29 |
6 | n/a | Bayer Ag | 4.25% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
7 | n/a | Gsk Plc | 4.03% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
8 | n/a | Roche Holding Ag Ordinary Shares New | 3.94% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
9 | BNTX | Biontech Se Adr | 3.89% | $92.16 | $23B | Biotechnology | Healthcare | N/A | N/A | 7.04 | N/A | N/A | N/A | 70 | +32.63% | $122 | -18.34% | 0.94 |
10 | EXEL | Exelixis Inc | 3.75% | $55.53 | $14B | Biotechnology | Healthcare | +72.24% | 17.54 | 17.70 | 0.45 | N/A | N/A | 59 | -8.28% | $51 | +26.67% | 0.52 |
11 | REGN | Regeneron Pharmaceuticals Inc | 3.72% | $672.15 | $69B | Biotechnology | Healthcare | +20.31% | 15.86 | 15.08 | 88.04 | N/A | N/A | 72 | +21.87% | $819 | +3.03% | 0.60 |
12 | TWST | Twist Bioscience Corp | 3.62% | $87.45 | $5.76B | Diagnostics & Research | Healthcare | -10.29% | N/A | N/A | N/A | N/A | N/A | 77 | +1.20% | $89 | -6.60% | 2.02 |
13 | INCY | Incyte Corp | 3.57% | $115.65 | $23B | Biotechnology | Healthcare | +27.16% | 15.82 | 15.06 | N/A | N/A | N/A | 61 | -1.58% | $114 | +7.88% | 0.57 |
14 | VRTX | Vertex Pharmaceuticals Inc | 3.56% | $480.50 | $121B | Biotechnology | Healthcare | +9.89% | 27.99 | 25.45 | 1.72 | N/A | N/A | 72 | +15.39% | $554 | +19.61% | 0.49 |
15 | n/a | Sanofi Sa | 3.28% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
16 | n/a | Genmab As | 3.18% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
17 | IBRX | Immunitybio Inc Ordinary Shares | 2.72% | $7.50 | $8.10B | Biotechnology | Healthcare | -9.78% | N/A | N/A | N/A | N/A | N/A | 83 | +73.45% | $13 | -8.69% | 1.56 |
18 | IDYA | Ideaya Biosciences Inc | 2.68% | $35.45 | $3.23B | Biotechnology | Healthcare | +8.12% | N/A | 4.65 | N/A | N/A | N/A | 76 | +47.50% | $52 | +10.45% | 1.10 |
19 | CAI | Caris Life Sciences Inc | 2.38% | $15.56 | $4.94B | Biotechnology | Healthcare | N/A | N/A | 43.29 | N/A | N/A | N/A | 71 | +73.52% | $27 | 0.00% | 1.42 |
20 | RCUS | Arcus Biosciences Inc | 2.16% | $28.17 | $3.52B | Biotechnology | Healthcare | +14.36% | N/A | N/A | N/A | N/A | N/A | 68 | +26.91% | $36 | -2.35% | 1.50 |
21 | n/a | Ono Pharmaceutical Co Ltd | 1.95% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
22 | CRSP | Crispr Therapeutics Ag | 1.84% | $46.99 | $4.95B | Biotechnology | Healthcare | +2.10% | N/A | 23.36 | N/A | N/A | N/A | 70 | +83.46% | $86 | -18.22% | 1.44 |
23 | IOVA | Iovance Biotherapeutics Inc | 1.42% | $5.02 | $2.08B | Biotechnology | Healthcare | -12.60% | N/A | N/A | N/A | N/A | N/A | 75 | +75.30% | $8.80 | -26.70% | 1.59 |
24 | NVAX | Novavax Inc | 1.32% | $7.88 | $1.39B | Biotechnology | Healthcare | -42.97% | N/A | 2.59 | 1.32 | N/A | N/A | 50 | +79.06% | $14 | -48.15% | 1.45 |
25 | NUVB | N/A | 1.17% | $6.26 | $2.04B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +96.96% | $12 | -6.73% | 1.47 |
26 | ABCL | Abcellera Biologics Inc Ordinary Shares | 1.17% | $5.80 | $2.05B | Biotechnology | Healthcare | N/A | N/A | 27.55 | N/A | N/A | N/A | 75 | +81.03% | $11 | -18.99% | 1.66 |
27 | n/a | N/A | 1.14% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
28 | VIR | Vir Biotechnology Inc | 1.06% | $9.23 | $1.55B | Biotechnology | Healthcare | -0.01% | N/A | 4.27 | N/A | N/A | N/A | 82 | +133.59% | $22 | -24.33% | 1.52 |
29 | CRVS | Corvus Pharmaceuticals Inc | 1.01% | $14.10 | $1.25B | Biotechnology | Healthcare | +53.96% | N/A | N/A | N/A | N/A | N/A | 78 | +136.38% | $33 | +43.22% | 0.75 |
30 | KURA | Kura Oncology Inc | 0.86% | $10.68 | $1.01B | Biotechnology | Healthcare | +15.40% | N/A | N/A | N/A | N/A | N/A | 76 | +191.85% | $31 | -10.92% | 1.06 |
31 | JANX | Janux Therapeutics Inc Ordinary Shares | 0.86% | $16.05 | $976M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 70 | +131.71% | $37 | -10.96% | 1.20 |
32 | n/a | N/A | 0.69% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
33 | OCGN | Ocugen Inc | 0.63% | $1.33 | $484M | Biotechnology | Healthcare | +8.79% | N/A | 13.07 | N/A | N/A | N/A | 78 | +759.40% | $11 | -29.62% | 1.71 |
34 | CTMX | Cytomx Therapeutics Inc | 0.59% | $3.52 | $652M | Biotechnology | Healthcare | N/A | 24.82 | 14.20 | 0.76 | N/A | N/A | 83 | +255.11% | $13 | -9.78% | 2.01 |
35 | RIGL | Rigel Pharmaceuticals Inc | 0.58% | $39.67 | $758M | Biotechnology | Healthcare | N/A | 6.87 | 9.01 | N/A | N/A | N/A | 65 | +36.63% | $54 | -1.37% | 1.10 |
36 | NTLA | Intellia Therapeutics Inc | 0.57% | $10.92 | $1.57B | Biotechnology | Healthcare | +8.10% | N/A | N/A | N/A | N/A | N/A | 62 | +139.65% | $26 | -41.00% | 1.77 |
37 | n/a | Abclon Inc | 0.54% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
38 | n/a | Shanghai Henlius Biotech Inc Class H | 0.50% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
39 | DNA | Ginkgo Bioworks Holdings Inc | 0.46% | $7.55 | $556M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 25 | +12.58% | $8.50 | -54.74% | 2.33 |
40 | DSGN | Design Therapeutics Inc | 0.46% | $11.87 | $844M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 82 | +76.92% | $21 | -8.04% | 1.13 |
41 | PACB | Pacific Biosciences Of California Inc | 0.46% | $1.36 | $475M | Medical Devices | Healthcare | +5.07% | N/A | N/A | N/A | N/A | N/A | 57 | +80.74% | $2.46 | -46.62% | 1.95 |
42 | n/a | Usd Cash | 0.45% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
43 | VSTM | Verastem Inc | 0.43% | $5.75 | $503M | Biotechnology | Healthcare | -2.77% | N/A | N/A | N/A | N/A | N/A | 77 | +160.87% | $15 | -33.08% | 1.38 |
44 | n/a | Valneva Se | 0.42% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
45 | ALVO | Alvotech | 0.41% | $3.41 | $1.12B | Drug Manufacturers - Specialty & Generic | Healthcare | -18.97% | N/A | 7.91 | N/A | N/A | N/A | 60 | +328.15% | $15 | 0.00% | 0.79 |
46 | n/a | Jpy/usd Purchased | 0.36% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
47 | PSNL | Personalis Inc | 0.35% | $13.34 | $1.65B | Diagnostics & Research | Healthcare | -3.14% | N/A | N/A | N/A | N/A | N/A | 75 | -0.37% | $13 | -10.06% | 2.30 |
48 | XNCR | Xencor Inc | 0.34% | $18.81 | $1.11B | Biotechnology | Healthcare | +10.21% | N/A | 68.03 | N/A | N/A | N/A | 76 | +50.61% | $28 | -10.32% | 1.42 |
49 | n/a | N/A | 0.13% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
50 | PRME | Prime Medicine Inc | 0.12% | $3.05 | $630M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 71 | +133.44% | $7.12 | 0.00% | 2.09 |
IDNA (ISHARES GENOMICS IMMUNOLOGY AND HEALTHCARE ETF) Sector Allocation
HEALTHCARE
62.90%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%